Table 1.
Summary of therapies targeting the tumor microenvironment in ovarian cancer. The agents listed below have demonstrated safety/efficacy in phase I/II trials, and/or improved survival in phase III trials.
|
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.